MCL 30 MCL 30 Dermablate Fractional Er:YAG (with MICROSPOT EXTENSION SET) 1
The third generation of the Dermablate series MCL 29 Dermablate Dermablate D1 MCL 30 Dermablate MCL29, the first Er:YAG laser for Dermatology, was introduced in 1996.
Specifications Wavelength: Power: Puls energy: 2,940 nm max. 12 W; voltage 230; 100; 120 V max. 1.5 J Fluence: 2 10 J/cm² (Ablation, limited) 2 100 J/cm² (Ablation, without fluence filter) 1 J/cm² in thermal mode 2 162 J/cm² (MicroSpot) Frequency: 1 / 4 / 8 / 10 / 15 Hz in ablation mode 20 Hz in thermal mode Spot size: 1 6 mm with VarioTEAM handpiece (Ablation, thermal mode) 13x13 mm with MicroSpot handpiece (Fractional, 169 MicroSpots with Ø 250 µm and 5% cover rate) Laser class: 4
Evidence of clinical success 1990: First clinical trials by R. Kaufmann et al. 1996: First Er:YAG Laser in dermatology introduced by Asclepion MCL 29 Dermablate by Asclepion-Meditec, more than 800 systems worldwide Germany: the Dermablate has became a standard tool for dermatologists in the treatment of a wide range of cutaneous lesions advantages of the Erbium laser compared to CO 2 lasers: - precise and safe ablation - very limited thermal damage (necrotic zone 30µm/70µm) - superficial treatments possible as well as deep ablation - reduced risk of scarring and pigmentation changes - many treatments require no anaesthesia - short healing process, little side effects
USPs Integrated suction system VarioTEAM handpiece Subablative mode (coagulation mode) Adjustable internal filter system Sterilizable distance holder Most homogenious beam profile Thermal mode Unbeaten reliability Fast amortisation Ugradeable with super fractional extension set (SFE)
Integrated filter system 1 filter - set contains: 1 HEPA filter 1 active coal filter 3 pre-filter sufficiant for 30 hours active use
VarioTEAM handpiece VarioTEAM handpiece (Ablation) with TEAM-Technology (Total Evacuation of Ablated Material) Very effective smoke evacuation Lowest smell nuisance No assistance necessary Cost reduction Patents: US 6 162 218 DE 197 106 76 with VarioSpot-Technology Spot size from 1 to 6 mm (adjustable in 1mm steps) Automatic spot size detection Automatic fluence adaption
Ablation in µm Ablation vs. Coagulation Ablation vs. Fluence - Different Mechanism of Er:YAG - Ablation Koagulation Fluence in J/cm 2 linear correlation constant ablation depth of 5 µm per 1 J/cm² (above ablation treshhold) Thermal Mode Specs: 1 J/cm², 20 Hz, N = 5... coagulation zone up to 400 µm depth (with single impulse up to 40 µm) Recommended parameters 5 6 J/cm² conservative 7 8 J/cm² normal 9 10 J/cm² aggressive treatment
Other Advantages FLUENCE directly adjustable: Easy to use No difficult calculation between energy and spot size Flat-Top-Profile: most homogenious spot ablation fractional
Other Advantages Modern design + Easy handling + Mobility
Absorption Coefficient [cm -1 ] Laser Selective absorption High absorbtion in water 100000 10000 Low absorbtion in melanin and hemoglobine 1000 100 Protein Desoxy-Hemoglobin Water Selective thermolysis (effective targeting and low side effects) 10 1 0.1 Oxy-Hemoglobin Melanin 0.01 0.001 Scattering 0.0001 100 200 300 400 500 1000 2000 3000 4000 5000 10000 Wavelength [nm]
Indications Removal of dermal and epidermal lesions: epidermal naevi, seborrhoic ceratoses, warts, naevuscellnaevus, hypertrophic scars, acne scars, xanthelasma, rhynophym, wrinkles, lentigines, actinic keratoses, syringoma full skin resurfacing soft laser peel skin refreshing New fractional laser therapy By soft and precise ablation.
Epidermal naevus By courtesy of Dr. R. Hartmann, Blaustein, Germany
Xanthelasma By courtesy of Dr. R. Hartmann, Blaustein, Germany
Lentigo senilis By courtesy of Prof. Dr. E. Haneke, Wuppertal, Germany
Skin resurfacing By courtesy of Dres. Hadravek and Salsicky, Plzen, CZ
Full skin resurfacing By courtesy of D. Fleming, M.D., Brisbane, Australia
Full skin resurfacing By courtesy of D. Fleming, M.D., Brisbane, Australia
Perioral ablation By courtesy of D. Fleming, M.D., Brisbane, Australia
Freckles By courtesy of D. Fleming, M.D., Brisbane, Australia
Seborrhoic ceratoses 3 weeks after treatment By courtesy of Dr. Paul Wood, Proderma, Bad Homburg, Germany
Dermal / epidermal Naevus 6 months after treatment By courtesy of Dr. Paul Wood, Proderma, Bad Homburg, Germany
Verruca seborrhoica pigmentosa 6 months after treatment By courtesy of Dr. W. Petrow, Bonn, Germany
Verruca seborrhoica pigmentosa 6 months after treatment By courtesy of Dr. W. Petrow, Bonn, Germany
Dermal NCN 6 months after treatment By courtesy of Dr. W. Petrow, Bonn, Germany
Milia By courtesy of Dr. M. Fuchs, Dr. Samimi-Fard, Germany
Syringoma By courtesy of Dr. M. Fuchs, Dr. Samimi-Fard, Germany
MicroSpot Superfractional Extension Set
MicroSpot Superfractional Extension Set
MicroSpot Superfractional Extension Set
MicroSpot Superfractional Extension Set
MicroSpot Superfractional Extension Set
MicroSpot Superfractional Extension Set involvement of the whole epidermis in the healing process Formation of heat shock proteins deep in the dermis Resulting in neocollagenesis
MicroSpot Superfractional Extension Set
MicroSpot Superfractional Extension Set
MicroSpot Superfractional Extension Set
MicroSpot Superfractional Extension Set
MicroSpot Superfractional Extension Set
MicroSpot Superfractional Extension Set
MicroSpot Superfractional Extension Set
MicroSpot Superfractional Extension Set
MicroSpot Superfractional Extension Set
MicroSpot Superfractional Extension Set
MicroSpot Superfractional Extension Set
MicroSpot Superfractional Extension Set
MicroSpot Superfractional Extension Set
MicroSpot Superfractional Extension Set
MicroSpot Superfractional Extension Set
MicroSpot Superfractional Extension Set
MicroSpot Superfractional Extension Set
MicroSpot Superfractional Extension Set new designed and patented handpiece automatic suction and lens cleaning cooling outlets integrated in distance holders maintenance free Microlens technology with 169 fractional spots per shot Up to 20 Hz (quickest fractional technology available)
MicroSpot Superfractional Extension Set immediately after one day after two days after Parameter: Handpiece 13 13mm Fluence 54 72 J/cm² Micro Pulse 3 4 Pass 1 3 three days after By courtesy of Dr. Daniel, Cassuto, Milano, Italy
MicroSpot Superfractional Extension Set 2 treatment within 4 weeks, each treatment with 2 passes, 10 J/cm 2, cover rate 15% and 4 shots on the same fractional spots, 2 months By courtesy of Dr. Daniel, Cassuto, Milano, Italy
MicroSpot Superfractional Extension Set 2 treatment within weeks, each treatment with 2 passes, 10 J/cm 2, cover rate 10% and 4 shots on the same fractional spots, 2 months By courtesy of Dr. Daniel, Cassuto, Milano, Italy
MicroSpot Superfractional Extension Set Post traumatic scar, 1 treatment, 2 passes, 10 J/cm 2, cover rate 15% and 4 shots on the same fractional spots By courtesy of Dr. Daniel, Cassuto, Milano, Italy
MicroSpot Superfractional Extension Set By courtesy of Dr. Feller-Heppt, University Hospital, Mannheim, Germany
MicroSpot Superfractional Extension Set Single treatment, 20 J/cm 2, 10 % cover rate, 3 shots on the same fractional spots, 1 and 7 days By courtesy of Dr. Feller-Heppt, University Hospital, Mannheim, Germany
MicroSpot Superfractional Extension Set Periorbital treatment only (forehead): single treatment, 20 J/cm 2, 10 % cover rate, 3 shots on the same fractional spots, 1 and 7 days By courtesy of Dr. Feller-Heppt, University Hospital, Mannheim, Germany
MicroSpot Superfractional Extension Set BEFORE AFTER 3 treatments MCL 30 Dermablate 126 J/cm², 13x13 mm fractional By courtesy of Prof. Kabir Sardana, Delhi
MicroSpot Superfractional Extension Set BEFORE AFTER 2 treatments MCL 30 Dermablate 126 J/cm², 13x13 mm fractional 2 treatments, 2 Passes By courtesy of Prof. Kabir Sardana, Delhi
MicroSpot Superfractional Extension Set BEFORE AFTER 3 treatments MCL 30 Dermablate 162 J/cm², 13x13 mm fractional 3 treatments, 3 Passes By courtesy of Prof. Kabir Sardana, Delhi
Bibliography Er:YAG-Laser Dermal lesions 1. Khatri KA. Ablation of cutaneous lesions using an erbium:yag laser. J Cosmet Laser Ther 2003; 5:1-4 2. Kaufmann R, Beier C. Erbium YAG laser therapy of skin lesions. Med Laser Appl 2001;16:252-263 3. Doi H, Ogawa Y, Hatoko M. Treatment of melanin-induced benign dermal lesions by an Erbium-YAG laser system. J Plast Reprod Surg 2000; 0:90-95 4. Wollina U, Konrad H, Karamfilov T. Treatment of common warts and actinic keratosis by Er:YAG laser. J Cutan Laser Ther 2001;3:63-66 5. Beier C, Kaufmann R. Efficacy of erbium:yag laser ablation in Darier disease and Hailey-Hailey disease. Arch Dermatol. 1999; 135(4):378-80 Aesthetic lesions (Skin Resurfacing) 1. Jasin ME. Achieving superior resurfacing results with the Erbium:YAG laser. Arch Facial Plast Surg 2002; 4:262-266 2. Perez MI, Bank DE. Facial skin resurfacing with the Erbium:YAG laser: new findings. Cosmetic Dermatology 1998;5:27-37 3. Khatri KA, Machado A, Magro C, Davenport S. Laser peel: facial rejuvenation with a superficial erbium:yag laser treatment. J Cutaneous Laser Ther 2000;2:119-123 4. Khatri KA, Ross V, Grevelink JM, Magro CM, Andersson RR. Comparison of erbium:yag and carbon dioxide lasers in resurfacing of facial rhytids. Arch Dermatol 1999;135(4):391-7
MCL 30 Dermablate: cleared, approved and registered worldwide FDA CE KFDA Thai-FDA SFDA PPAD USA Europe Korea Thailand China Taiwan Made in Germany